应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09939 开拓药业-B
交易中 04-24 09:59:31
0.960
+0.000
0.00%
最高
1.000
最低
0.920
成交量
23.00万
今开
0.920
昨收
0.960
日振幅
8.33%
总市值
4.30亿
流通市值
4.30亿
总股本
4.47亿
成交额
22.44万
换手率
0.05%
流通股本
4.47亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
天士力2023年扭亏:净利润同比增长超五倍 医药商业收入下滑
中国网财经 · 04-23 19:14
天士力2023年扭亏:净利润同比增长超五倍 医药商业收入下滑
【兴证医药】一图速览2024Q1公募基金医药持仓变化
兴证医药健康 · 04-23 17:49
【兴证医药】一图速览2024Q1公募基金医药持仓变化
上交所:终止对上海健耕医药科技股份有限公司首次公开发行股票并在科创板上市审核
澎湃新闻 · 04-23 17:32
上交所:终止对上海健耕医药科技股份有限公司首次公开发行股票并在科创板上市审核
胰岛素集采将开标,券商看好医药板块主题性投资机会
环球网 · 04-23 17:08
胰岛素集采将开标,券商看好医药板块主题性投资机会
百克生物:4月22日接受机构调研,中信医药、国信医药等多家机构参与
证券之星 · 04-23 16:54
百克生物:4月22日接受机构调研,中信医药、国信医药等多家机构参与
4月23日西山科技跌8.52%,申万菱信医药先锋股票A基金重仓该股
证券之星 · 04-23 16:27
4月23日西山科技跌8.52%,申万菱信医药先锋股票A基金重仓该股
4月23日首药控股-U涨6.75%,鹏华医药科技股票A基金重仓该股
证券之星 · 04-23 16:26
4月23日首药控股-U涨6.75%,鹏华医药科技股票A基金重仓该股
4月23日星湖科技涨停分析:化学原料药,新冠药物,医药概念热股
证券之星 · 04-23 15:38
4月23日星湖科技涨停分析:化学原料药,新冠药物,医药概念热股
4月23日甘李药业涨停分析:减肥药,化学原料药,医药概念热股
证券之星 · 04-23 15:37
4月23日甘李药业涨停分析:减肥药,化学原料药,医药概念热股
港股异动 | 医药股午后拉升走强 创新药政策向好态势明显 二季度后板块有望持续转暖
智通财经 · 04-23 13:55
港股异动 | 医药股午后拉升走强 创新药政策向好态势明显 二季度后板块有望持续转暖
港股午评:恒生科技指数涨2.85% 医药、科技股走强
东方财富Choice... · 04-23 12:05
港股午评:恒生科技指数涨2.85% 医药、科技股走强
开拓药业-B盘中异动 早盘股价大涨5.00%
自选股智能写手 · 04-23 09:30
开拓药业-B盘中异动 早盘股价大涨5.00%
汇添富基金郑磊旗下汇添富创新医药一季报最新持仓,重仓恒瑞医药
证券之星 · 04-22 18:23
汇添富基金郑磊旗下汇添富创新医药一季报最新持仓,重仓恒瑞医药
港股收盘(04.22) | 恒指收涨1.77% 科网股领跑大市 汽车股、资源股显著下挫
智通财经 · 04-22 16:38
港股收盘(04.22) | 恒指收涨1.77% 科网股领跑大市 汽车股、资源股显著下挫
加仓宁德时代(300750.SZ)!谢治宇:深度挖掘AI、智驾、医药等产业链
智通财经网 · 04-22 16:24
加仓宁德时代(300750.SZ)!谢治宇:深度挖掘AI、智驾、医药等产业链
A股业绩预告预喜股大涨,爱科科技、嘉诚国际等领涨
金融界 · 04-22 13:34
A股业绩预告预喜股大涨,爱科科技、嘉诚国际等领涨
A股午评 | 沪指跌0.47% 军工板块掀涨停潮 消费、医药回暖
智通财经网 · 04-22 11:34
A股午评 | 沪指跌0.47% 军工板块掀涨停潮 消费、医药回暖
A股医药医疗股震荡反弹
港股那点事 · 04-22 10:19
A股医药医疗股震荡反弹
开拓药业-B现涨超17% GT20029治疗男性脱发中国II期临床试验达到主要终点
新浪港股 · 04-22 10:06
开拓药业-B现涨超17% GT20029治疗男性脱发中国II期临床试验达到主要终点
亚盛医药-B盘中异动 快速拉升5.10%报16.500港元
自选股智能写手 · 04-22 09:54
亚盛医药-B盘中异动 快速拉升5.10%报16.500港元
加载更多
公司概况
公司名称:
开拓药业-B
所属市场:
SEHK
上市日期:
--
主营业务:
开拓药业有限公司是一家临床阶段新药开发商,专注于研究癌症药物及其他雄激素受体(AR)相关疾病药物。该公司的主要在研药物是普克鲁胺。该药物正在中国进行转移性去势抵抗性前列腺癌(mCRPC)的III期临床试验。该公司处于临床阶段在研药物还包括一种II期小分子在研药物Pyrilutamide、一种II期单克隆抗体在研药物ALK-1、一种I期mTOR抑制剂Detorsertib、以及一种hedgehog信号转导途径抑制剂GT1708F。
发行价格:
--
{"stockData":{"symbol":"09939","market":"HK","secType":"STK","nameCN":"开拓药业-B","latestPrice":0.96,"timestamp":1713923917385,"preClose":0.96,"halted":0,"volume":230000,"delay":0,"floatShares":447499600,"shares":447499600,"eps":-2.6686134,"marketStatus":"交易中","marketStatusCode":2,"change":0,"latestTime":"04-24 09:59:31","open":0.92,"high":1,"low":0.92,"amount":224420,"amplitude":0.083333,"askPrice":0.96,"askSize":1000,"bidPrice":0.95,"bidSize":1500,"shortable":0,"etf":0,"ttmEps":-2.6686135335443235,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1713931200000},"adr":0,"listingDate":1590076800000,"adjPreClose":0.96,"openAndCloseTimeList":[[1713922200000,1713931200000],[1713934800000,1713945600000]],"volumeRatio":1.103936,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09939","defaultTab":"news","newsList":[{"id":"2429024111","title":"天士力2023年扭亏:净利润同比增长超五倍 医药商业收入下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2429024111","media":"中国网财经","top":-1,"share":"https://www.laohu8.com/m/news/2429024111?lang=zh_cn&edition=full","pubTime":"2024-04-23 19:14","pubTimestamp":1713870888,"startTime":"0","endTime":"0","summary":"中国网财经4月23日讯 天士力近日披露2023年年报。2023年,天士力实现营业收入86.74亿元,同比增长0.42%;归母净利润10.71亿元,同比增长505.34%;扣非净利润11.81亿元,同比增长60.11%,拟向全体股东每10股派3.3元(含税)。 对于扭亏的原因,天士力表示,主要系报告期内金融资产公允价值变动损失低于上年所致。天士力期内...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/O0kbJCe0GNsbm1wptWm4Fu0s8dqt1HnTcVx4MOFl9gD-kAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/O0kbJCe0GNsbm1wptWm4Fu0s8dqt1HnTcVx4MOFl9gD-kAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240423A08K7Q00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240423A08K7Q00","is_publish_highlight":false,"gpt_icon":0},{"id":"2429162059","title":"【兴证医药】一图速览2024Q1公募基金医药持仓变化","url":"https://stock-news.laohu8.com/highlight/detail?id=2429162059","media":"兴证医药健康","top":-1,"share":"https://www.laohu8.com/m/news/2429162059?lang=zh_cn&edition=full","pubTime":"2024-04-23 17:49","pubTimestamp":1713865740,"startTime":"0","endTime":"0","summary":"本公司并不对使用本报告所包含的材料产生的任何直接或间接损失或与此相关的其他任何损失承担任何责任。同时,本公司对本报告所含信息可在不发出通知的情形下做出修改,投资者应当自行关注相应的更新或修改。本公司没有将此意见及建议向报告所有接收者进行更新的义务。除非另有书面显示,否则本报告中的所有材料的版权均属本公司。任何完整的研究观点应以兴业证券股份有限公司正式发布的报告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["research"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA4NjAxNzEzNw==&mid=2650184757&idx=1&sn=1d74a7e099a6905d194f95e46689efcc&chksm=86b7e6adfc0a1f3aedc192f6da96cc11a2cf2d45868b4e08ed11808fb4b6d99466aaca11fa3f&scene=0#rd","is_publish_highlight":false,"gpt_icon":0},{"id":"2429690471","title":"上交所:终止对上海健耕医药科技股份有限公司首次公开发行股票并在科创板上市审核","url":"https://stock-news.laohu8.com/highlight/detail?id=2429690471","media":"澎湃新闻","top":-1,"share":"https://www.laohu8.com/m/news/2429690471?lang=zh_cn&edition=full","pubTime":"2024-04-23 17:32","pubTimestamp":1713864720,"startTime":"0","endTime":"0","summary":"4月23日,上交所发布关于终止对上海健耕医药科技股份有限公司首次公开发行股票并在科创板上市审核的决定。因上海健耕医药科技股份有限公司及其保荐人撤回发行上市申请,根据《上海证券交易所股票发行上市审核规则》第六十三条的有关规定,本所终止其发行上市审核。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-04-23/doc-inasvmtu8788053.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-04-23/doc-inasvmtu8788053.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429166983","title":"胰岛素集采将开标,券商看好医药板块主题性投资机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2429166983","media":"环球网","top":-1,"share":"https://www.laohu8.com/m/news/2429166983?lang=zh_cn&edition=full","pubTime":"2024-04-23 17:08","pubTimestamp":1713863299,"startTime":"0","endTime":"0","summary":"针对中标价格的设置,集采设定了三条中标价格线,低价产品存在提价空间。对此西南证券分析认为,相较前次方案,此次集采更鼓励产品A组中标。同时针对医药板块的投资机会,西南证券认为在海外宏观降息预期下,叠加政策、估值、基本面三个维度,仍有结构性机会,主要体现在“创新+出海”、“院内医疗刚性需求”和“低估值+业绩反转”等主题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.huanqiu.com/article/4HVcRE9yhpz","is_publish_highlight":false,"gpt_icon":0},{"id":"2429631461","title":"百克生物:4月22日接受机构调研,中信医药、国信医药等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2429631461","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429631461?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:54","pubTimestamp":1713862475,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年4月23日百克生物发布公告称公司于2024年4月22日接受机构调研,中信医药、国信医药、海通医药、华安医药、华鑫医药、华源医药、华福医药、开源医药、民生医药、申万医药、信达医药、东北医药、西南医药、中银医药、中金医药、中泰医药、其他117家机构、投资者、东方医药、东吴医药、方正医药、国海医药、国金医药、国联医药、国投医药参与。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300031381.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429150056","title":"4月23日西山科技跌8.52%,申万菱信医药先锋股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2429150056","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429150056?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:27","pubTimestamp":1713860831,"startTime":"0","endTime":"0","summary":"证券之星消息,4月23日西山科技跌8.52%,收盘报70.35元,换手率9.14%,成交量1.17万手,成交额8191.53万元。重仓西山科技的公募基金请见下表:该股最近90天内共有1家机构给出评级,增持评级1家。根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为申万菱信医药先锋股票A。申万菱信医药先锋股票A目前规模为2.13亿元,最新净值0.5824,较上一交易日上涨0.8%,近一年下跌32.65%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300029776.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429715078","title":"4月23日首药控股-U涨6.75%,鹏华医药科技股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2429715078","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429715078?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:26","pubTimestamp":1713860789,"startTime":"0","endTime":"0","summary":"证券之星消息,4月23日首药控股-U涨6.75%,收盘报48.84元,换手率2.17%,成交量1.21万手,成交额5806.58万元。重仓首药控股-U的前十大公募基金请见下表:该股最近90天内共有3家机构给出评级,买入评级3家;过去90天内机构目标均价为52.2。根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共11家,其中持有数量最多的公募基金为鹏华医药科技股票A。鹏华医药科技股票A目前规模为25.94亿元,最新净值0.9918,较上一交易日上涨2.51%,近一年下跌19.37%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300029721.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429154153","title":"4月23日星湖科技涨停分析:化学原料药,新冠药物,医药概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2429154153","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429154153?lang=zh_cn&edition=full","pubTime":"2024-04-23 15:38","pubTimestamp":1713857916,"startTime":"0","endTime":"0","summary":"证券之星消息,星湖科技涨停收盘,收盘价4.79元。该股于9点25分涨停,未打开涨停,截止收盘封单资金为1.11亿元,占其流通市值2.32%。4月23日的资金流向数据方面,主力资金净流入1516.79万元,占总成交额37.98%,游资资金净流出646.17万元,占总成交额16.18%,散户资金净流出870.62万元,占总成交额21.8%。近5日资金流向一览见下表:该股为化学原料药,新冠药物,医药概念热股,当日化学原料药概念上涨1.13%,新冠药物概念上涨0.97%,医药概念上涨0.93%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300024282.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429615411","title":"4月23日甘李药业涨停分析:减肥药,化学原料药,医药概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2429615411","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429615411?lang=zh_cn&edition=full","pubTime":"2024-04-23 15:37","pubTimestamp":1713857838,"startTime":"0","endTime":"0","summary":"证券之星消息,甘李药业涨停收盘,收盘价47.99元。该股于11点10分涨停,未打开涨停,截止收盘封单资金为9768.36万元,占其流通市值0.38%。4月23日的资金流向数据方面,主力资金净流入1.88亿元,占总成交额22.1%,游资资金净流出7390.59万元,占总成交额8.7%,散户资金净流出1.14亿元,占总成交额13.4%。近5日资金流向一览见下表:该股为减肥药,化学原料药,医药概念热股,当日减肥药概念上涨1.49%,化学原料药概念上涨1.13%,医药概念上涨0.93%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300024229.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429153834","title":"港股异动 | 医药股午后拉升走强 创新药政策向好态势明显 二季度后板块有望持续转暖","url":"https://stock-news.laohu8.com/highlight/detail?id=2429153834","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429153834?lang=zh_cn&edition=full","pubTime":"2024-04-23 13:55","pubTimestamp":1713851752,"startTime":"0","endTime":"0","summary":"消息面上,近日,北京市医保局印发《北京市支持创新医药高质量发展若干措施》。东海证券近日研报指出,今年以来包括对创新药的明确支持、集采续约条款的持续优化等,行业政策向好态势明显;二季度以后板块整体有望持续转暖向好。中长期来看,持续看好创新药、特色器械等代表新质生产力发展方向的投资机会;中短期来看,重点关注品牌中药、连锁药店、血制品等低估值、高股息,成长稳健的相关板块及个股的投资机会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107395.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429134599","title":"港股午评:恒生科技指数涨2.85% 医药、科技股走强","url":"https://stock-news.laohu8.com/highlight/detail?id=2429134599","media":"东方财富Choice...","top":-1,"share":"https://www.laohu8.com/m/news/2429134599?lang=zh_cn&edition=full","pubTime":"2024-04-23 12:05","pubTimestamp":1713845112,"startTime":"0","endTime":"0","summary":"【港股午评:恒生科技指数涨2.85% 医药、科技股走强】港股早盘指数高开高走,恒生指数涨1.64%,恒生科技指数涨2.85%。板块方面,制药、AIGC概念、节假日概念、网络直播、猪肉等板块涨幅居前;半导体、建筑产品、化学制品、燃料电池、紫光系等板块跌幅居前。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1353,202404233055756857.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429844951","title":"开拓药业-B盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429844951","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429844951?lang=zh_cn&edition=full","pubTime":"2024-04-23 09:30","pubTimestamp":1713835848,"startTime":"0","endTime":"0","summary":"2024年04月23日早盘09时30分,开拓药业-B股票出现异动,股价大幅拉升5.00%。截至发稿,该股报1.071港元/股,成交量17.85万股,换手率0.04%,振幅1.96%。资金方面,该股资金流入13.203万港元,流出530港元。开拓药业-B股票所在的药品行业中,整体涨幅为0.06%。其相关个股中,联康生物科技集团、开拓药业-B、中国同辐涨幅较大,振幅较大的相关个股有联康生物科技集团、联邦制药、开拓药业-B,振幅分别为4.82%、2.14%、1.96%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042309304879227518&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042309304879227518&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429267946","title":"汇添富基金郑磊旗下汇添富创新医药一季报最新持仓,重仓恒瑞医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2429267946","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429267946?lang=zh_cn&edition=full","pubTime":"2024-04-22 18:23","pubTimestamp":1713781439,"startTime":"0","endTime":"0","summary":"证券之星消息,4月22日汇添富基金旗下郑磊管理的汇添富创新医药主题混合型基金公布一季报,近1年净值增长率-31.46%。与上一季度相比,该基金前十大重仓股新增迈瑞医疗,新产业;其中恒瑞医药持仓占比10.34%,为该基金第一大重仓股;药明康德,同仁堂等退出前十大重仓股;详细数据如下:以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042200022033.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429912087","title":"港股收盘(04.22) | 恒指收涨1.77% 科网股领跑大市 汽车股、资源股显著下挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2429912087","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429912087?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:38","pubTimestamp":1713775108,"startTime":"0","endTime":"0","summary":"截止收盘,恒生指数涨1.77%或287.55点,报16511.69点,本全日成交额1049.25亿港元;恒生国企指数涨1.47%,报5831.26点;恒生科技指数涨1.78%,报3336.35点。截至收盘,跌8.33%,报97.45港元,成交额26.11亿港元,拖累恒指19.18点。其中Model 3起售价降至23.19万元,Model Y起售价降至24.99万元。热门异动股1. 玄武云午后飙升,截至收盘,涨60.78%,报0.82港元。玄武云午间发布公告称,将因应市况行使购回授权及2024年购回授权以于公开市场上购回股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1106503.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429912629","title":"加仓宁德时代(300750.SZ)!谢治宇:深度挖掘AI、智驾、医药等产业链","url":"https://stock-news.laohu8.com/highlight/detail?id=2429912629","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2429912629?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:24","pubTimestamp":1713774248,"startTime":"0","endTime":"0","summary":"4月22日,兴证全球基金知名基金经理谢治宇旗下的兴全合润和兴全合宜发布2024年第一季度报告。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20240422/20240422162423_95906.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240422/20240422162423_95906.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1106462.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429994396","title":"A股业绩预告预喜股大涨,爱科科技、嘉诚国际等领涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2429994396","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2429994396?lang=zh_cn&edition=full","pubTime":"2024-04-22 13:34","pubTimestamp":1713764052,"startTime":"0","endTime":"0","summary":"在今日上午的股市交易中,A股市场出现小幅调整,上证指数和深证成指分别下滑0.47%和0.17%。在业绩预告方面,上周五晚间至昨晚,一批A股上市公司披露了2024年一季度业绩预告。爱科科技、嘉诚国际和海鸥住工等公司股价均大幅上涨。总的来说,尽管A股市场整体出现调整,但农林牧渔板块的逆势大涨以及部分业绩预告预喜的公司的股价上涨为市场带来了一定的活力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221334188b4475d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221334188b4475d0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429993207","title":"A股午评 | 沪指跌0.47% 军工板块掀涨停潮 消费、医药回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=2429993207","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2429993207?lang=zh_cn&edition=full","pubTime":"2024-04-22 11:34","pubTimestamp":1713756884,"startTime":"0","endTime":"0","summary":"A股早盘冲高回落,三大指数盘中一度均翻红。盘面上,军工板块掀涨停潮,大金融板块走强,白酒、养殖、医药等板块涨幅居前。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20240422/20240422113931_43098.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240422/20240422113931_43098.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1106333.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429960508","title":"A股医药医疗股震荡反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=2429960508","media":"港股那点事","top":-1,"share":"https://www.laohu8.com/m/news/2429960508?lang=zh_cn&edition=full","pubTime":"2024-04-22 10:19","pubTimestamp":1713752340,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 格隆汇4月22日|同和药业、万孚生物涨超10%,亚辉龙、三诺生物、祥生医疗、贝达药业、翰宇药业、艾迪药业等多股涨超5%。 \n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-22/doc-inassmqz1145398.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-22/doc-inassmqz1145398.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429964478","title":"开拓药业-B现涨超17% GT20029治疗男性脱发中国II期临床试验达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2429964478","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2429964478?lang=zh_cn&edition=full","pubTime":"2024-04-22 10:06","pubTimestamp":1713751571,"startTime":"0","endTime":"0","summary":"开拓药业-B(09939)早盘高开,股价上涨17.24%,现报1.02港元,成交额339.57万港元。\n 消息面上,开拓药业公告,其自主研发的新型靶向雄激素受体(AR)的蛋白降解嵌合体(PROTAC)化合物GT20029酊外用治疗男性雄激素性脱发(脱发或AGA)的中国II期临床试验达到主要研究终点,其结果具有统计学显著性及临床意义,且安全性和耐受性良好。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-22/doc-inassmqz1139514.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-22/doc-inassmqz1139514.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429645169","title":"亚盛医药-B盘中异动 快速拉升5.10%报16.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429645169","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429645169?lang=zh_cn&edition=full","pubTime":"2024-04-22 09:54","pubTimestamp":1713750851,"startTime":"0","endTime":"0","summary":"2024年04月22日早盘09时54分,亚盛医药-B股票出现波动,股价大幅拉升5.10%。截至发稿,该股报16.500港元/股,成交量17.31万股,换手率0.06%,振幅5.10%。资金方面,该股资金流入207.765万港元,流出43.5274万港元。亚盛医药-B股票所在的生物技术行业中,整体跌幅为0.33%。其相关个股中,金斯瑞生物科技、亚盛医药-B、创胜集团-B涨幅较大,振幅较大的相关个股有科笛-B、来凯医药-B、金斯瑞生物科技,振幅分别为9.06%、5.97%、5.94%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404220954117a545e81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404220954117a545e81&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kintor.com.cn","stockEarnings":[{"period":"1week","weight":0.1429},{"period":"1month","weight":0.0213},{"period":"3month","weight":-0.2615},{"period":"6month","weight":-0.6336},{"period":"1year","weight":-0.8313},{"period":"ytd","weight":-0.411}],"compareEarnings":[{"period":"1week","weight":0.0357},{"period":"1month","weight":0.02},{"period":"3month","weight":0.0584},{"period":"6month","weight":-0.0127},{"period":"1year","weight":-0.1569},{"period":"ytd","weight":-0.0128}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"开拓药业有限公司是一家临床阶段新药开发商,专注于研究癌症药物及其他雄激素受体(AR)相关疾病药物。该公司的主要在研药物是普克鲁胺。该药物正在中国进行转移性去势抵抗性前列腺癌(mCRPC)的III期临床试验。该公司处于临床阶段在研药物还包括一种II期小分子在研药物Pyrilutamide、一种II期单克隆抗体在研药物ALK-1、一种I期mTOR抑制剂Detorsertib、以及一种hedgehog信号转导途径抑制剂GT1708F。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.058646},{"month":2,"riseRate":0.75,"avgChangeRate":0.213088},{"month":3,"riseRate":0.25,"avgChangeRate":0.062774},{"month":4,"riseRate":0.75,"avgChangeRate":0.55435},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.091618},{"month":6,"riseRate":0.25,"avgChangeRate":-0.077338},{"month":7,"riseRate":0.75,"avgChangeRate":0.030119},{"month":8,"riseRate":0.25,"avgChangeRate":-0.047081},{"month":9,"riseRate":0,"avgChangeRate":-0.284122},{"month":10,"riseRate":0.25,"avgChangeRate":-0.084422},{"month":11,"riseRate":0.75,"avgChangeRate":0.089012},{"month":12,"riseRate":0.25,"avgChangeRate":-0.241375}],"exchange":"SEHK","name":"开拓药业-B","nameEN":"KINTOR PHARMA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供开拓药业-B(09939)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"开拓药业-B,09939,开拓药业-B股票,开拓药业-B股票老虎,开拓药业-B股票老虎国际,开拓药业-B行情,开拓药业-B股票行情,开拓药业-B股价,开拓药业-B股市,开拓药业-B股票价格,开拓药业-B股票交易,开拓药业-B股票购买,开拓药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供开拓药业-B(09939)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}